APA (7th ed.) Citation

Ross, G., Stewart, P., Mensing, G., Chin, M., Howell, H., Mangus, H., & Savage, W. (2023). Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria. Blood, 142(Supplement 1), 923. https://doi.org/10.1182/blood-2023-175011

Chicago Style (17th ed.) Citation

Ross, Gayle, Peter Stewart, George Mensing, Melanie Chin, Haley Howell, Heidi Mangus, and William Savage. "Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria." Blood 142, no. Supplement 1 (2023): 923. https://doi.org/10.1182/blood-2023-175011.

MLA (9th ed.) Citation

Ross, Gayle, et al. "Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria." Blood, vol. 142, no. Supplement 1, 2023, p. 923, https://doi.org/10.1182/blood-2023-175011.